Case 02 / Beauty buyer sales deck / 2026

SILT LAB

Audience: Specialty-beauty buyers and regional distributors
Format: HTML → PDF presentation system
Scale: 13 slides
System direction: Sediment Ledger

A four-SKU core should advance only when the shelf story and the evidence gaps are equally clear.

01 / Category signal

Use market context to frame a buyer question—not to claim traction.

The opening evidence establishes the commercial setting, then separates that setting from the fictional brand. The page gives the buyer a reason to inspect the offer without presenting public category growth as SILT LAB performance.

Public beauty context is attributed separately from Auren interpretation.
No retailer relationship, sales history or product performance is claimed.
The audience remains a specialty-beauty buyer or regional distributor.

02 / Assortment & price

Turn a tactile brand story into a range that can be compared.

The middle sequence assigns each product a clear role, shows how the four-SKU core creates sellable moments and makes the illustrative buyer-margin logic readable without hiding its assumptions.

All SKU, size, MSRP, cost and margin values are synthetic.
Tables and price ladders remain native presentation content.
The system favors a legible range over a decorative product wall.

03 / Readiness & close

Close on sample review—not on an invented national forecast.

Readiness requirements remain visible before the final recommendation. The close asks whether the four-SKU core should move to sample review after claims, labeling, supply and test conditions can be supported.

The proposed 24-door, 90-day test is illustrative.
Readiness fields are evidence gates, not completed certifications.
No sell-through, reorder, conversion or launch result is presented.

Source and commercial-claim boundary.

01
Circana public reporting supplies category context; it does not validate SILT LAB or its commercial potential.
02
RangeMe guidance informs buyer fields and margin structure; all SILT LAB values remain synthetic.
03
FDA material informs labeling and MoCRA readiness questions; no compliance or registration status is claimed.
04
No client-confidential material, retailer relationship, certification, sales result or testimonial is used.